This post was originally published on this site
Also, the recently identified highly transmissible COVID-19 omicron variant could attract even more investor interest in the industry. The global biotechnology industry is projected to reach $2.44 trillion by 2028, registering a 15.8% CAGR.
Given the industry’s solid growth prospects, Wall Street analysts expect quality biotech stocks Esperion Therapeutics Inc. (ESPR) and CTI BioPharma Corp. (CTIC), which are currently trading at less than $10, to deliver significant upside in the coming months. So, we think these stocks could be great additions to one’s watchlist.